The ADXS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADXS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADXS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADXS Detailed Price Forecast - CNN Money||View ADXS Detailed Summary - Google Finance|
|View ADXS Detailed Summary - Yahoo! Finance||View ADXS Stock Research & Analysis - Zacks.com|
|View ADXS Trends & Analysis - Trade-Ideas||View ADXS Major Holders - Barrons|
|View ADXS Call Transcripts - NASDAQ||View ADXS Breaking News & Analysis - Seeking Alpha|
|View ADXS Annual Report - CompanySpotlight.com||View ADXS OTC Short Report - OTCShortReport.com|
|View ADXS Fundamentals - TradeKing||View ADXS SEC Filings - Bar Chart|
|View Historical Prices for ADXS - The WSJ||View Performance/Total Return for ADXS - Morningstar|
|View the Analyst Estimates for ADXS - MarketWatch||View the Earnings History for ADXS - CNBC|
|View the ADXS Earnings - StockMarketWatch||View ADXS Buy or Sell Recommendations - MacroAxis|
|View the ADXS Bullish Patterns - American Bulls||View ADXS Short Pain Metrics - ShortPainBot.com|
|View ADXS Stock Mentions - StockTwits||View ADXS Stock Mentions - PennyStockTweets|
|View ADXS Stock Mentions - Twitter||View ADXS Investment Forum News - Investor Hub|
|View ADXS Stock Mentions - Yahoo! Message Board||View ADXS Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADXS - SECform4.com||View Insider Transactions for ADXS - Insider Cow|
|View ADXS Major Holdings Summary - CNBC||View Insider Disclosure for ADXS - OTC Markets|
|View Insider Transactions for ADXS - Yahoo! Finance||View Institutional Holdings for ADXS - NASDAQ|
|View ADXS Stock Insight & Charts - FinViz.com||View ADXS Investment Charts - StockCharts.com|
|View ADXS Stock Overview & Charts - BarChart||View ADXS User Generated Charts - Trading View|
Analysis: Positioning to Benefit within Advaxis, e.l.f. Beauty, Heron Therapeutics, PVH, Energy Recovery, and A. O. Smith — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Monday May 14, 2018
NEW YORK, May 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Advaxis, ...
Recently Presented Preclinical Data Show Potential for ADXS-NEO as Anti-Cancer Immunotherapy Agent
Posted on Friday May 11, 2018
Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, provides an update on recently presented preclinical data demonstrating the anti-cancer potential of their Lm vector that presents tumor neoantigens, and is being evaluated in the ADXS-NEO program. ADXS-NEO is derived from the Company’s proprietary Lm Technology and is being developed in partnership with Amgen. These preclinical findings were discussed in poster presentations at the recent American Association for Cancer Research (AACR) Annual Meeting.
Advaxis Announces Executive Leadership Changes
Posted on Monday April 23, 2018
Advaxis, Inc. , a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that Kenneth A.
Preclinical Data Highlighting ADXS-Hot as Immunotherapy with Potential to Target Hotspot Cancer Mutations across Multiple Cancer Types Presented in Poster Discussion at The AACR Annual Meeting
Posted on Tuesday April 17, 2018
Advaxis, Inc. , a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces the presentation of ADXS-HOT preclinical data in a poster discussion entitled “Targeting Shared Hotspot Cancer Mutations with a Listeria monocytogenes Immunotherapy Induce Potent Anti-Tumor Immunity” at the American Association for Cancer Research Annual ...